HCNC
🇧🇪Belgium
- Country
- 🇧🇪Belgium
- Ownership
- Private, Subsidiary
- Established
- 1977-01-01
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.uzbrussel.be
Sub-type Specific Genomic Mutations in sBOTs
Recruiting
- Conditions
- Ovarian Neoplasm Epithelial
- Interventions
- Genetic: genomic mutations study
- First Posted Date
- 2019-03-21
- Last Posted Date
- 2023-05-16
- Lead Sponsor
- Universitair Ziekenhuis Brussel
- Target Recruit Count
- 20
- Registration Number
- NCT03883542
- Locations
- 🇧🇪
Universitair Ziekenhuis UZBrussel, Jette, Brussels, Belgium
Blood Eosinophil Measurements in Patients With Chronic Obstructive Pulmonary Disease
Completed
- Conditions
- Chronic Obstructive Pulmonary Disease
- Interventions
- Other: Blood sampling
- First Posted Date
- 2019-02-25
- Last Posted Date
- 2020-03-30
- Lead Sponsor
- Universitair Ziekenhuis Brussel
- Target Recruit Count
- 50
- Registration Number
- NCT03853642
- Locations
- 🇧🇪
Universiatir Ziekenhuis Brussel, Brussels, Belgium
Nanofat on Wound Healing and Scar Formation
Not Applicable
- Conditions
- ScarsDelayed Wound HealingHypertrophic ScarPost Inflammatory HyperpigmentationDonor Site Complication
- Interventions
- Procedure: Nanofat injection
- First Posted Date
- 2019-02-21
- Last Posted Date
- 2019-02-21
- Lead Sponsor
- Universitair Ziekenhuis Brussel
- Target Recruit Count
- 15
- Registration Number
- NCT03850119
Assessment of Adherence to Controller Inhalation Medication in Asthma- and COPD Patients.
Not Applicable
Completed
- Conditions
- AsthmaCOPDAdherence, Medication
- Interventions
- Other: The 12-question TAIOther: Information from patients fileOther: The COPD Assessment Test (CAT)Other: The Asthma Control Test (ACT)
- First Posted Date
- 2019-01-02
- Last Posted Date
- 2019-05-29
- Lead Sponsor
- Universitair Ziekenhuis Brussel
- Target Recruit Count
- 141
- Registration Number
- NCT03791658
- Locations
- 🇧🇪
Universitair Ziekenhuis Brussel, Brussel, Brussels, Belgium
Intratumoral TriMix Injections in Early Breast Cancer Patients
Phase 1
Recruiting
- Conditions
- Breast Cancer FemaleEarly-stage Breast Cancer
- Interventions
- Drug: PlaceboDrug: Trimix
- First Posted Date
- 2018-12-27
- Last Posted Date
- 2022-05-19
- Lead Sponsor
- Universitair Ziekenhuis Brussel
- Target Recruit Count
- 36
- Registration Number
- NCT03788083
- Locations
- 🇧🇪
UZ Brussel, Jette, Brussel, Belgium
Myo-inositol as Pretreatment in Hyperandrogenic PCOS Patients
- First Posted Date
- 2018-12-06
- Last Posted Date
- 2018-12-06
- Lead Sponsor
- Universitair Ziekenhuis Brussel
- Target Recruit Count
- 134
- Registration Number
- NCT03767569
- Locations
- 🇧🇪
Universitair Ziekenhuis Brussel, Brussels, Belgium
Initiation of Ovarian Stimulation With Recombinant-human FSH (Bemfola®) in the Late Follicular Phase
Phase 3
Completed
- Conditions
- Infertility, Female
- Interventions
- Combination Product: Early follicular phase stimulation with recombinant-human FSHCombination Product: Late follicular phase stimulation with recombinant-human FSH
- First Posted Date
- 2018-12-06
- Last Posted Date
- 2023-05-16
- Lead Sponsor
- Universitair Ziekenhuis Brussel
- Target Recruit Count
- 71
- Registration Number
- NCT03767218
- Locations
- 🇧🇪
Universitair Ziekenhuis Brussel, Brussel, Belgium
Dabrafenib/Trametinib/Hydroxychloroquine for Advanced Pretreated BRAF V600 Mutant Melanoma
- First Posted Date
- 2018-11-27
- Last Posted Date
- 2021-04-28
- Lead Sponsor
- Universitair Ziekenhuis Brussel
- Target Recruit Count
- 63
- Registration Number
- NCT03754179
- Locations
- 🇧🇪
UZ Brussel, Jette, Brabant, Belgium
Anaesthesia and mHealth
- Conditions
- AnesthesiaCell PhoneMobile Applications
- First Posted Date
- 2018-11-21
- Last Posted Date
- 2019-04-30
- Lead Sponsor
- Universitair Ziekenhuis Brussel
- Target Recruit Count
- 400
- Registration Number
- NCT03750084
- Locations
- 🇧🇪
Universitair Ziekenhuis Brussel, Jette, Brussel, Belgium
Intratumoral Injection of Autologous CD1c (BDCA-1)+ Myeloid Dendritic Cells Plus Talimogene Laherparepvec (T-VEC)
Phase 1
- Conditions
- Melanoma
- Interventions
- Other: CD1c (BDCA-1)+ myDC
- First Posted Date
- 2018-11-20
- Last Posted Date
- 2020-12-29
- Lead Sponsor
- Universitair Ziekenhuis Brussel
- Target Recruit Count
- 18
- Registration Number
- NCT03747744
- Locations
- 🇧🇪
UZ Brussel, Brussels, Belgium
© Copyright 2025. All Rights Reserved by MedPath